Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: Belgium Clear all

77 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20022
20033
20044
20052
20062
20072
20088
20096
201013
20113
20122
20131
20142
20153
20162
20171
20181
20193
20204
20211
20221
20232
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed66
Terminated6
Recruiting3
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S19
AstraZeneca12
Boehringer Ingelheim10
Eli Lilly and Company9
Sanofi5
Janssen Research & Development, LLC4
GlaxoSmithKline3
Novartis Pharmaceuticals3
Bayer2
Lexicon Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 277
Diabetes Mellitus24
Cardiovascular Diseases4
Obesity4
Coronary Artery Disease3
Glucose Metabolism Disorders3
Kidney Diseases3
Renal Insufficiency, Chronic3
Diabetes Mellitus, Type 12
Diabetic Nephropathies2

Trials

Showing 1 to 25 of 77. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.